DNA in situ hybridization as an adjunct in tumor diagnosis

American Journal of Clinical Pathology

Volumn 112, Issue 1 SUPPL. 1, 1999, Pages

  Fletcher, Jonathan A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

CHROMOSOME ABERRATION; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; DNA HYBRIDIZATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOCUS; HISTOCHEMISTRY; HUMAN; IN SITU HYBRIDIZATION; KARYOTYPE; PRIORITY JOURNAL; REVIEW; TUMOR DIAGNOSIS;

CHROMOSOME ABERRATIONS; DNA, NEOPLASM; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; NEOPLASMS;

EID: 0033506997     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Press MF, Bernstein L, Thomas PA, et al. HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas. J Clin Oncol. 1997;15:2894-2904.
2. Pietras RJ, Pegram MD, Finn RS, et al. Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs. Oncogene. 1998;17:2235-2249.
3. Pegram MD, Lipton A, Hayes DF, et al. Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment. J Clin Oncol. 1998;16:2659-2671.
4. Fletcher JA, Kozakewich HP, Hoffer FA, et al. Diagnostic relevance of clonal cytogenetic aberrations in malignant soft-tissue tumors. N Engl J Med. 1991;324:436-442.
5. Ried T. Interphase cytogenetics and its role in molecular diagnostics of solid tumors. Am J Pathol. 1998;152:325-327.
6. Hopman AH, Claessen S, Speel EJ. Multi-colour brightfield in situ hybridization on tissue sections. Histochem Cell Biol. 1997;108:291-298.
7. Speel EJ, Ramaekers FC, Hopman AH. Cytochemical detection systems for in situ hybridization, and the combination with immunocytochemistry: "Who is still afraid of red, green and blue?" Histochem J. 1995;27:833-858.
8. Ried T, Lengauer C, Lipp M, et al. Evaluation of the utility of interphase cytogenetics to detect residual cells with a malignant genotype in mixed cell populations: a Burkitt lymphoma model. DNA Cell Biol. 1993;12:637-643.
9. Xiao S, Renshaw AA, Cibas ES, et al. Novel fluorescence in situ hybridization approaches in solid tumors: characterization of frozen specimens, touch preparations, and cytologic preparations. Am J Pathol. 1995;147:896-904.
10. Anastasi J, Le Beau MM, Vardiman JW, et al. Detection of trisomy 12 in chronic lymphocytic leukemia by fluorescence in situ hybridization to interphase cells: a simple and sensitive method. Blood. 1992;79:1796-1801.
11. Schofield DE, Fletcher JA. Trisomy 12 in pediatric granulosa-stromal cell tumors: demonstration by a modified method of fluorescence in situ hybridization on paraffin-embedded material. Am J Pathol. 1992;141:1265-1269.
12. Wolman SR, Waldman FM, Balazs M. Complementarity of interphase and metaphase chromosome analysis in human renal tumors. Genes Chromosome Cancer. 1993;6:17-23.
13. Qian J, Bostwick DG, Takahashi S, et al. Comparison of fluorescence in situ hybridization analysis of isolated nuclei and routine histological sections from paraffin-embedded prostatic adenocarcinoma specimens. Am J Pathol. 1996;149:1193-1199.
14. Tkachuk DC, Westbrook CA, Andreeff M, et al. Detection of bcr-abl fusion in chronic myelogeneous leukemia by in situ hybridization. Science. 1990;250:559-562.
15. Kallioniemi A, Kallioniemi OP, Sudar D, et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science. 1992;258:818-821.
16. Kallioniemi OP, Kallioniemi A, Piper J, et al. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosome Cancer. 1994;10:231-243.
17. Knuutila S, Bjorkqvist AM, Autio K, et al. DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. Am J Pathol. 1998;152:1107-1123.
18. Ried T, Just KE, Holtgreve-Grez H, et al. Comparative genomic hybridization of formalin-fixed, paraffin-embedded breast tumors reveals different patterns of chromosomal gains and losses in fibroadenomas and diploid and aneuploid carcinomas. Cancer Res. 1995;55:5415-5423.
19. Veldman T, Vignon C, Schrock E, et al. Hidden chromosome abnormalities in haematological malignancies detected by multicolour spectral karyotyping. Nature Genet. 1997;15:406-410.
20. Macville M, Schrock E, Padilla-Nash H, et al. Comprehensive and definitive molecular cytogenetic characterization of HeLa cells by spectral karyotyping. Cancer Res. 1999;59:141-150.
21. Delattre O, Zucman J, Plougastel B, et al. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature. 1992;359:162-165.
22. Sorensen PH, Lessnick SL, Lopez-Terrada D, et al. A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG. Nature Genet. 1994;6:146-151.
23. Jeon IS, Davis JN, Braun BS, et al. A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1. Oncogene. 1995;10:1229-1234.
24. Peter M, Couturier J, Pacquement H, et al. A new member of the ETS family fused to EWS in Ewing tumors. Oncogene. 1997;14:1159-1164.
25. Ishida S, Yoshida K, Kaneko Y, et al. The genomic breakpoint and chimeric transcripts in the EWSR1-ETV4/E1AF gene fusion in Ewing sarcoma. Cytogenet Cell Genet. 1998;82:278-283.
26. Clark J, Benjamin H, Gill S, et al. Fusion of the EWS gene to CHN, a member of the steroid/thyroid receptor gene superfamily, in a human myxoid chondrosarcoma. Oncogene. 1996;12:229-235.
27. Ladanyi M, Gerald W. Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor. Cancer Res. 1994;54:2837-2840